CADIAN CAPITAL MANAGEMENT LP 13D and 13G filings for MaxCyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 2:28 pm Sale | 2025-12-31 | 13G | MAXCYTE INC MXCT | CADIAN CAPITAL MANAGEMENT LP | 3,683,052 3.500% | -4,544,551 (-55.24%) | Filing |
| 2025-11-14 1:40 pm Sale | 2025-09-30 | 13G | MAXCYTE INC MXCT | CADIAN CAPITAL MANAGEMENT LP | 8,227,603 7.700% | -1,116,821 (-11.95%) | Filing |
| 2025-02-13 6:17 pm Purchase | 2024-12-31 | 13G | MAXCYTE INC MXCT | CADIAN CAPITAL MANAGEMENT LP | 9,344,424 8.900% | 1,155,476 (+14.11%) | Filing |
| 2024-11-13 7:14 pm Purchase | 2024-09-30 | 13G | MAXCYTE INC MXCT | CADIAN CAPITAL MANAGEMENT LP | 8,188,948 7.800% | 2,544,050 (+45.07%) | Filing |
| 2024-02-14 12:25 pm Purchase | 2023-12-31 | 13G | MAXCYTE INC MXCT | CADIAN CAPITAL MANAGEMENT LP | 5,644,898 5.500% | 5,644,898 (New Position) | Filing |